Merck · 4 hours ago
Associate Specialist Engineering
Merck is seeking a motivated scientist/engineer to join the Biologics Downstream Operations team within BioProcess Research and Development. The successful candidate will support downstream pilot plant activities and collaborate with various teams to implement operational improvements and new technologies.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Large Scale purification support
Facilitate knowledge transfers between development and operations teams
Batch documentation within an electronic laboratory system
Participate in scheduling discussions within the operations team
Collaborate with development colleagues on the implementation of novel technologies and process analytical tools
Work collaboratively with pilot plant operations, upstream and solution prep teams
Work collaboratively with process development scientists from across BPR&D
Support safety and training initiatives
Qualification
Required
BS in Chemical/Biochemical/Biomedical Engineering/Biology/Chemistry with 1+ year(s) of relevant experience
Strong skills in laboratory experimentation and documentation, with demonstrated ability to write clear comprehensive operating procedures
Strong communication and interpersonal skills to work in cross-functional team environments
Lead small projects or sub-teams including vendor interactions
Strong troubleshooting skills
Preferred
Demonstrated ability for independent execution of experiments
Familiarity with protein purification techniques (chromatography, NFF & TFF filtration)
Experience with Akta Bioprocess Skid, BioSMB, Akta Ready/Flux
Ability to work with lab automation teams on improvement projects
Benefits
Medical
Dental
Vision healthcare
Other insurance benefits (for employee and family)
Retirement benefits, including 401(k)
Paid holidays
Vacation
Compassionate and sick days
Company
Merck
Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.
Funding
Current Stage
Public CompanyTotal Funding
$5.59MKey Investors
Private Capital Advisors"Gavi, the Vaccine Alliance"
2018-11-25Post Ipo Equity· $0.59M
2016-01-21Series Unknown· $5M
1980-12-19IPO
Leadership Team
Recent News
2026-02-05
Genetic Engineering News
2026-02-05
Company data provided by crunchbase